Elevated CD39 activity drives cytarabine resistance in acute myeloid leukemia by activating a cAMP-dependent mitochondrial stress response, which enhances mitochondrial function and biogenesis. This evidence concerns the gene ENTPD1 and acute myeloid leukemia.